Outset Medical
About: Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Employees: 354
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
599% more capital invested
Capital invested by funds: $23.4M [Q4 2024] → $163M (+$140M) [Q1 2025]
43.16% more ownership
Funds ownership: 40.07% [Q4 2024] → 83.23% (+43.16%) [Q1 2025]
12% less call options, than puts
Call options by funds: $2.35M | Put options by funds: $2.67M
19% less funds holding
Funds holding: 74 [Q4 2024] → 60 (-14) [Q1 2025]
45% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 31
98% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 42
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$21
8%
upside
Avg. target
$21
8%
upside
High target
$21
8%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
RBC Capital Shagun Singh | 8%upside $21 | Sector Perform Maintained | 21 May 2025 |
Financial journalist opinion
Positive
Seeking Alpha
4 days ago
Why Outset Medical's Rock-Bottom Valuation Masks Explosive Growth
The company's business model leverages recurring revenue streams and strong customer retention, supporting stable long-term growth. Key risks include potential regulatory changes and execution challenges that could impact future earnings. With FDA hurdles behind it and sales momentum building, Outset's Tablo is regaining traction across hospitals and ICU settings.
Positive
Zacks Investment Research
2 weeks ago
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Neutral
GlobeNewsWire
1 month ago
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 46th annual Healthcare conference on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time.
Neutral
GlobeNewsWire
1 month ago
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee Gaeta as Chief Financial Officer (CFO), effective immediately. In addition to leading Finance, Ms. Gaeta will have responsibility for Outset's Information Technology and Human Resources organizations. She succeeds Nabeel Ahmed who is leaving the company to pursue other opportunities.
Neutral
GlobeNewsWire
1 month ago
Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of healthcare industry veteran Kevin O'Boyle to its Board of Directors and as chair of its Audit Committee. With Mr. O'Boyle's appointment, the company also announced that Dale E. Jones has stepped down from the Board.
Neutral
GlobeNewsWire
2 months ago
Outset Medical to Present at RBC Global Healthcare Conference
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 20, 2025, at 10:30 a.m. Eastern time.
Neutral
Seeking Alpha
2 months ago
Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript
Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
2 months ago
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $3.24 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $8.55 per share a year ago.
Neutral
GlobeNewsWire
2 months ago
Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined
SAN JOSE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March 31, 2025.
Neutral
GlobeNewsWire
2 months ago
OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ:OM) on behalf of long-term stockholders following a class action complaint that was filed against Outset Medical on August 29, 2024 with a Class Period from August 1, 2022 to August 7, 2024. Our investigation concerns whether the board of directors of Outset Medical have breached their fiduciary duties to the company.
Charts implemented using Lightweight Charts™